New ADHD Formulations, Patches, and Patient Trust
Psychiatric Times
New ADHD formulations, including patches and a triple reuptake inhibitor, are expanding treatment options for adult ADHD. These innovations allow for more personalized care and improved patient adherence. The discussion emphasizes the importance of building patient trust when introducing novel delivery methods and medications.
All articles from 27 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.